Relationship between RANKL and neuroendocrine activation in elderly males with heart failure

Endocrine

Volumn 37, Issue 1, 2010, Pages 148-156

  Loncar, Goran ^a   Bozic, Biljana ^b,c   Cvorovic, Vojkan ^d   Radojicic, Zoran ^c   Dimkovic, Sinisa ^a   Markovic, Natasa ^a   Prodanovic, Nenad ^b   Lepic, Toplica ^b   Putnikovic, Biljana ^d   Popovic Brkic, Vera ^e  

^a Clinical Medical Center Zvezdara   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d Clinical Hospital Center Zemun   (Serbia)

^e CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Adiponectin; Heart failure; NT pro BNP; OPG; RANKL

Indexed keywords

ADIPONECTIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BODY MASS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE CLEARANCE; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYSTOLIC HEART FAILURE; VOLUNTEER;

ADIPONECTIN; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NEUROSECRETORY SYSTEMS; OSTEOPROTEGERIN; PEPTIDE FRAGMENTS; RANK LIGAND; STATISTICS AS TOPIC;

EID: 75949121286     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-009-9282-z     Document Type: Article

References (34)

1. VL Roger SA Weston MM Redfield JP Hellermann-Homan J Killian BP Yawn SJ Jacobsen 2004 Trends in heart failure incidence and survival in a community-based population JAMA 292 344 350 10.1001/jama.292.3.344 1:CAS:528:DC%2BD2cXlvFaju7k%3D 15265849 (Pubitemid 38944258)
2. E Braunwald 2008 Biomarkers in heart failure N. Engl. J. Med. 358 2148 2159 10.1056/NEJMra0800239 1:CAS:528:DC%2BD1cXlvFCrsL8%3D 18480207 (Pubitemid 351679601)
3. WH Tang GS Francis DA Morrow LK Newby CP Cannon RL Jesse AB Storrow RH Christenson FS Apple J Ravkilde AH Wu National Academy of Clinical Biochemistry Laboratory Medicine 2007 National academy of clinical biochemistry laboratory medicine practice guidelines: clinical utilisation of cardiac biomarker testing in heart failure Circulation 116 5 e99 e109 10.1161/CIRCULATIONAHA.107.185267 1:CAS:528:DC%2BD2sXotValtL8%3D 17630410 (Pubitemid 47450268)
4. BF Boyce L Xing 2008 Functions of RANKL/RANK/OPG in bone modeling and remodeling Arch. Biochem. Biophys. 473 139 146 10.1016/j.abb.2008.03.018 1:CAS:528:DC%2BD1cXlsFOgt7c%3D 18395508
5. DL Lacey E Timms HL Tan MJ Kelley CR Dunstan T Burgess R Elliott A Colombero G Elliott S Scully H Hsu J Sullivan N Hawkins E Davy C Capparelli A Eli YX Qian S Kaufman I Sarosi V Shalhoub G Senaldi J Guo J Delaney WJ Boyle 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 93 165 176 10.1016/S0092-8674(00)81569-X 1:CAS:528:DyaK1cXivVyhtrg%3D 9568710 (Pubitemid 28180851)
6. YY Kong H Yoshida I Sarosi HL Tan E Timms C Capparelli S Morony AJ Oliveira-dos-Santos G Van A Itie W Khoo A Wakeham CR Dunstan DL Lacey TW Mak WJ Boyle JM Penninger 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature 397 6717 315 323 10.1038/16852 1:CAS:528:DyaK1MXhtVOqs7w%3D 9950424 (Pubitemid 29061638)
7. YY Kong WJ Boyle JM Penninger 2000 Osteoprotegerin ligand: a regulator of immune responses and bone physiology Immunol. Today 21 10 495 502 10.1016/S0167-5699(00)01718-7 1:CAS:528:DC%2BD3cXmvFyltrY%3D 11071528 (Pubitemid 30782212)
8. DM Anderson E Maraskovsky WL Billingsley WC Dougall ME Tometsko ER Roux MC Teepe RF DuBose D Cosman L Galibert 1997 A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function Nature 390 175 179 10.1038/36593 1:CAS:528:DyaK2sXnsVOgurY%3D 9367155 (Pubitemid 27507987)
9. A Rogers RE Eastell 2005 Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment J. Clin. Endocrinol. Metab. 90 11 6323 6331 10.1210/jc.2005-0794 1:CAS:528:DC%2BD2MXht1altLzO 16105967 (Pubitemid 41606564)
10. H Yasuda N Shima N Nakagawa K Yamaguchi M Kinosaki S Mochizuki A Tomoyasu K Yano M Goto A Murakami E Tsuda T Morinaga K Higashio N Udagawa N Takahashi T Suda 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL Proc. Natl Acad. Sci. USA 95 3597 3602 10.1073/pnas.95.7.3597 1:CAS:528:DyaK1cXitlKjsLY%3D 9520411 (Pubitemid 28173173)
11. M Schoppet AM Sattler JR Schaefer M Herzum B Maisch LC Hofbauer 2003 Increased osteoprotegerin serum levels in men with coronary artery disease J. Clin. Endocrinol. Metab. 88 3 1024 1028 10.1210/jc.2002-020775 1:CAS:528:DC%2BD3sXit1egtbc%3D 12629080 (Pubitemid 36337751)
12. S Jono Y Ikari A Shioi K Mori T Miki K Hara Y Nishizawa 2002 Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease Circulation 106 10 1192 1194 10.1161/01.CIR.0000031524.49139.29 1:CAS:528:DC%2BD38XntVKksrk%3D 12208791 (Pubitemid 34988634)
13. S Kiechl G Schett G Wenning K Redlich M Oberhollenzer A Mayr P Santer J Smolen W Poewe J Willeit 2004 Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease Circulation 109 18 2175 2180 10.1161/01.CIR.0000127957.43874.BB 1:CAS:528:DC%2BD2cXjs1eisrk%3D 15117849 (Pubitemid 38625393)
14. T Ueland R Jemtland K Godang J Kjekshus A Hognestad T Omland IB Squire L Gullestad J Bollerslev K Dickstein P Aukrust 2004 Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction J. Am. Coll. Cardiol. 44 10 1970 1976 10.1016/j.jacc.2004.06.076 1:CAS:528: DC%2BD2cXpslGguro%3D 15542278 (Pubitemid 39473280)
15. T Ueland A Yndestad E ∅ie G Florholmen B Halvorsen SS Frøland S Simonsen G Christensen L Gullestad P Aukrust 2005 Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure Circulation 111 19 2461 2468 10.1161/01.CIR.0000165119.62099.14 1:CAS:528:DC%2BD2MXjvFOis7w%3D 15883214 (Pubitemid 40696134)
16. S Helske PT Kovanen KA Lindstedt K Salmela J Lommi H Turto K Werkkala M Kupari 2007 Increased circulating concentrations and augmented myocardial extraction of osteoprotegerin in heart failure due to left ventricular pressure overload Eur. J. Heart Fail. 9 4 357 363 10.1016/j.ejheart.2006.10.015 1:CAS:528:DC%2BD2sXjsVeqsrw%3D 17254844 (Pubitemid 46441975)
17. N Ouchi R Shibata K Walsh 2006 Cardioprotection by adiponectin Trends Cardiovasc. Med. 16 141 146 10.1016/j.tcm.2006.03.001 1:CAS:528: DC%2BD28XlvF2ntrk%3D 16781946 (Pubitemid 43867326)
18. Y Okamoto S Kihara N Ouchi M Nishida Y Arita M Kumada K Ohashi N Sakai I Shimomura H Kobayashi N Terasaka T Inaba T Funahashi Y Matsuzawa 2002 Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice Circulation 106 22 2767 2770 10.1161/01.CIR.0000042707.50032.19 1:CAS:528:DC%2BD38XoslSnsbw%3D 12451000 (Pubitemid 35396973)
19. C Kistorp J Faber S Galatius F Gustafsson J Frystyk A Flyvbjerg P Hildebrandt 2005 Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure Circulation 112 12 1756 1762 10.1161/CIRCULATIONAHA. 104.530972 1:CAS:528:DC%2BD2MXpvFGqsLw%3D 16157772 (Pubitemid 41372115)
20. SD Anker R Sharma 2002 The syndrome of cardiac cachexia Int. J. Cardiol. 85 1 51 66 10.1016/S0167-5273(02)00233-4 12163209 (Pubitemid 34887972)
21. The Criteria Committee of the New York Heart Association. (1994). Criteria for diagnosis and treatment of heart failure. Little, Brown and Company
22. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories 2002 ATS statement: guidelines for the six-minute walk test Am. J. Respir. Crit. Care Med. 166 l 111 117
23. FE Silvestry RE Kerber MM Brook JD Carroll KM Eberman SA Goldstein HC Herrmann S Homma R Mehran DL Packer AF Parisi T Pulerwitz JB Seward TS Tsang MA Wood 2009 Echocardiography-guided interventions J. Am. Soc. Echocardiogr. 22 3 213 231 10.1016/j.echo.2008.12.013 19258174
24. N Massy-Westropp W Rankin M Ahern J Krishnan TC Hearn 2004 Measuring grip strength in normal adults: reference ranges and a comparison of electronic and hydraulic instruments J. Hand Surg. 29 3 514 519 10.1016/j.jhsa.2004.01.012 (Pubitemid 38658186)
25. DW Cockroft MH Gault 1976 Prediction of creatinine clearance from serum creatinine Nephron 16 31 41 10.1159/000180580
26. EM Wilson HR Gunasinghe ML Coker P Sprunger D Lee-Jackson B Bozkurt A Deswal DL Mann FG Spinale 2002 Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure J. Card. Fail. 8 6 390 398 10.1054/jcaf.2002.129659 1:CAS:528:DC%2BD3sXotFChsA%3D%3D 12528092 (Pubitemid 36055741)
27. J George S Patal D Wexler Y Sharabi E Peleg Y Kamari E Grossman D Sheps G Keren 2006 Circulating adiponectin concentrations in patients with congestive heart failure Heart 92 10 1420 1424 10.1136/hrt.2005.083345 1:CAS:528: DC%2BD28Xht1Shur3K 16621874 (Pubitemid 44578832)
28. T Tamura Y Furukawa R Taniguchi Y Sato K Ono H Horiuchi Y Nakagawa T Kita T Kimura 2007 Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure Circ. J. 71 5 623 630 10.1253/circj.71.623 1:CAS:528:DC%2BD2sXlvVSmtbk%3D 17456982 (Pubitemid 46683348)
29. O Tsukamoto M Fujita M Kato S Yamazaki Y Asano A Ogai H Okazaki M Asai Y Nagamachi N Maeda Y Shintani T Minamino M Asakura I Kishimoto T Funahashi H Tomoike M Kitakaze 2009 Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure J. Am. Coll. Cardiol. 53 22 2070 2077 10.1016/j.jacc.2009.02.038 1:CAS:528:DC%2BD1MXotFOlt7o%3D 19477358
30. MH Gannagé-Yared F Fares M Semaan S Khalife S Jambart 2006 Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population Clin. Endocrinol. (Oxf.) 64 6 652 658 10.1111/j.1365-2265.2006.02522.x (Pubitemid 43775003)
31. MB McEntegart B Awede MC Petrie N Sattar FG Dunn NG MacFarlane JJ McMurray 2007 Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide Eur. Heart J. 28 7 829 835 10.1093/eurheartj/ehm033 1:CAS:528:DC%2BD2sXmtFeksb8%3D 17403719 (Pubitemid 47343601)
32. JV Patel M Sosin HS Lim I Chung N Panja RC Davis EA Hughes GY Lip 2007 Raised leptin concentrations among South Asian patients with chronic heart failure Int. J. Cardiol. 122 1 34 40 10.1016/j.ijcard.2006.11.013 17187880 (Pubitemid 47503344)
33. GS Filippatos K Tsilias K Venetsanou E Karambinos D Manolatos A Kranidis J Antonellis F Kardaras L Anthopoulos G Baltopoulos 2000 Leptin serum levels in cachectic heart failure patients. Relationship with tumor necrosis factor-alpha system Int. J. Cardiol. 76 2-3 117 122 10.1016/S0167-5273(00)00397-1 1:STN:280:DC%2BD3M7ktlymtg%3D%3D 11104865 (Pubitemid 30946998)
34. KK Koh MJ Quon SH Han WJ Chung JY Ahn YH Seo IS Choi EK Shin 2005 Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia J. Am. Coll. Cardiol. 45 10 1649 1653 10.1016/j.jacc.2005.02.052 1:CAS:528:DC%2BD2MXktVOjtrg%3D 15893182 (Pubitemid 40704501)